ARIX BIOSCIENCE PLC Logo

ARIX BIOSCIENCE PLC

ARIX | IL

Overview

Corporate Details

ISIN(s):
GB00BD045071
LEI:
213800OVT3AHQCXNIX43
Country:
United Kingdom
Address:
1 More London Place, SE1 2AF London
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

ARIX BIOSCIENCE PLC invests in innovative life sciences companies, supporting breakthroughs in biotechnology and healthcare.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-02-12 14:02
Delisting Announcement
Arix Bioscience Plc - Results of 2nd General Meeting
English 123.9 KB
2024-02-12 13:00
Post-Annual General Meeting Information
Scheme Effective
English 28.0 KB
2024-02-12 08:00
Delisting Announcement
Suspension of Trading in Shares
English 19.2 KB
2024-02-07 12:30
M&A Activity
Transaction Update
English 30.8 KB
2024-01-29 14:06
Delisting Announcement
Arix Bioscience Plc - Results of 1st General Meeting
English 61.5 KB
2024-01-29 13:15
Post-Annual General Meeting Information
Results of First General Meeting
English 28.6 KB
2024-01-24 18:30
Major Shareholding Notification
Holding(s) in Company
English 66.9 KB
2024-01-23 11:42
Pre-Annual General Meeting Information
Arix Bioscience Plc - Circular and Notice of Second General Meeting
English 138.5 KB
2024-01-23 08:00
Pre-Annual General Meeting Information
Update on the Scheme and Publication of Notice of Second General Meeting
English 39.2 KB
2024-01-22 08:00
M&A Activity
Update on the Scheme and Resignation of Directors
English 22.4 KB
2024-01-19 08:01
Earnings Release
Financial update on Harpoon Therapeutics acquisition by Merck (MSD)
English 11.7 KB
2024-01-19 08:00
Net Asset Value
Unaudited NAV for December 2023
English 15.1 KB
2024-01-08 18:15
M&A Activity
Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)
English 58.4 KB
2024-01-05 08:00
Proxy Solicitation & Information Statement
Publication of Circular and RTW Bio Prospectus
English 43.5 KB
2024-01-04 18:30
Major Shareholding Notification
Holding(s) in Company
English 66.4 KB

Automate Your Workflow. Get a real-time feed of all ARIX BIOSCIENCE PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ARIX BIOSCIENCE PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ARIX BIOSCIENCE PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Israel TMIS
THERACRYF PLC Logo
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom TCF
Toleranzia AB Logo
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden TOL
UCAR Logo
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France ALUCR
VERICI DX PLC Logo
AI-powered diagnostic tests for the kidney transplant market, predicting organ rejection and injury.
United Kingdom VRCI
Vicore Pharma Holding Logo
Develops AT2 receptor drugs and a digital therapeutic for pulmonary fibrosis.
Sweden VICO
R&D in renewable energy & manufacturing specialized tools for automotive & engineering.
Slovakia 0OCW
Xlife Sciences AG Logo
A life sciences incubator commercializing early-stage academic research for healthcare markets.
Switzerland XLS
Yoshi Innovation Spolka Akcyjna Logo
A tech fund incubating MedTech, biotech, and defense ventures with investment and IP protection.
Poland YOS

Talk to a Data Expert

Have a question? We'll get back to you promptly.